Clinical Trials Update: Sept. 13, 2006
Rheumatoid Arthritis Allergies and Asthma Hot Flash
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate the effectiveness of an investigational medication in controlling rheumatoid arthritis when taken in addition to methotrexate. Volunteers 18 or older who have active rheumatoid arthritis, are taking 10 to 25 mg. of methotrexate per week, and have at least six tender joints and at least six swollen joints may qualify.
The research sites are located across the United States.
Allergies and Asthma
For many asthmatics, a common trigger of asthma flare ups is an underlying hay fever allergy. This is often referred to as "seasonal allergic asthma." This study will evaluate an investigational medicine to determine if it can lead to long-term improvement in asthma symptoms after a short period of treatment.
Candidates 18-65 may be included whose asthma symptoms get worse in the autumn hay fever season, have used asthma medication during prior fall hay fever seasons, and have not been hospitalized for asthma or received allergy shots for seasonal allergens within the past five years.
Research sites are in Pennsylvania, Ohio, and Maryland.
A non-hormonal investigational medication is being tested to see if it can help control hot flashes. If you are at least 40 years old, have multiple hot flashes and night sweats each week, had your last period at least six months ago, and are prepared NOT to use hormone therapy or antidepressants during the 12-week study, you may qualify to participate. Volunteers may be compensated for travel, and will receive physical exams, EKG, and study-related lab tests at no cost.
The research site is in Chaska, Minn.
Copyright 2006 Thomson CenterWatch. All rights reserved.